Evidence map›Paper›PMID 37940833›Full record

ArticleBiological trace element research2024

Blocking SIG1R Along with Low Cadmium Exposure Display Anti-cancer Qualities in Both MCF7 and MDA-MB-231 Cells.

Barış Yıldız, Ramazan Demirel, Hatice Beşeren Havadar, Gülden Yıldız, Cem Öziç, Nadide Nabil Kamiloğlu, Özkan Özden

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Design, synthesis, characterization,Future medicinal chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Barış YıldızInstitute of Health Sciences, Department of Physiology, Kafkas University, 36100, Kars, Turkey.
Ramazan DemirelDepartment of Bioengineering, Institute of Natural and Applied Sciences, Kafkas University, 36100, Kars, Turkey.
Hatice Beşeren HavadarDeparment of Medical Pathology, Centre of Health Research and Training Hospital, Kafkas University, 36100, Kars, Turkey.
Gülden YıldızDeparment of Medical Pathology, Centre of Health Research and Training Hospital, Kafkas University, 36100, Kars, Turkey.
Cem ÖziçDepartment of Medical Biology, School of Medicine, Kafkas University, 36100, Kars, Turkey.
Nadide Nabil KamiloğluDepartment of Physiology, Faculty of Veterinary Medicine, Kafkas University, 36100, Kars, Turkey.
Özkan ÖzdenDepartment of Bioengineering, Faculty of Engineering and Architecture, Kafkas University, 36100, Kars, Turkey. ozzkan1@gmail.com.
Kafkas University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sigma-1 receptor (SIG1R) is a chaperone that modulates inositol 1,4,5-trisphosphate receptor type1 (IP

Indexed as

Antineoplastic AgentsApoptosisReceptors, sigmaSigma-1 ReceptorBreast NeoplasmsCadmiumCell Line, TumorCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorFemaleHumansMCF-7 CellsMDA-MB-231 CellsAntineoplastic AgentsCadmiumReceptors, sigmaSigma-1 ReceptorApoptosisBreast cancerCadmiumIP3R1SIG1R

Identifiers

PMID37940833
OpenAlexW4388509212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.